Wettswil, Switzerland

Kerstin Möhle

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Kerstin Möhle

Introduction

Kerstin Möhle, an accomplished inventor based in Wettswil, Switzerland, has made significant contributions to the field of pharmaceutical science with a focus on cyclic peptides and macrocyclic compounds. Holding four patents, Möhle's work is at the forefront of innovative solutions for treating infectious diseases and various health conditions.

Latest Patents

Among her latest patents, Möhle has developed novel cyclic peptides aimed at providing protection against respiratory syncytial virus (RSV). This invention encompasses cyclic peptides, conjugates that include lipopeptide building blocks, synthetic virus-like particles, and pharmaceutical compositions formulated for use as medicaments. These advancements are particularly focused on preventing and reducing the risk of infectious diseases associated with RSV. Additionally, Möhle's patent on conformationally constrained, fully synthetic macrocyclic compounds outlines a new series of 12-30 membered macrocyclic ring systems designed to interact with specific biological targets. These macrocycles exhibit potential therapeutic activity for conditions such as gastrointestinal disorders, central nervous system diseases, ocular hypertension, and more.

Career Highlights

Kerstin Möhle has worked with notable organizations, including Polyphor AG, where she has contributed to the development of innovative pharmaceutical solutions. Her academic background is highlighted by her association with the University of Zurich, fostering collaboration between scientific research and practical applications.

Collaborations

Throughout her career, Möhle has collaborated with esteemed individuals such as Daniel Obrecht and Philipp Ermert. These partnerships have bolstered her research efforts, driving the advancement of her innovative ideas into practical healthcare solutions.

Conclusion

Kerstin Möhle's dedication to innovation in the pharmaceutical industry exemplifies the impact of focused research and collaboration. With her groundbreaking work on cyclic peptides and macrocyclic compounds, she continues to pave the way for new therapeutic strategies to combat infectious diseases and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…